RECOMBINATE is a Kit in the Plasma Derivative category. It is labeled and distributed by Baxalta Us Inc.. The primary component is .
Product ID | 0944-2842_74f3de5a-1800-4125-9181-0497bb20269c |
NDC | 0944-2842 |
Product Type | Plasma Derivative |
Proprietary Name | RECOMBINATE |
Generic Name | Antihemophilic Factor Recombinant |
Dosage Form | Kit |
Marketing Start Date | 2009-04-10 |
Marketing Category | BLA / BLA |
Application Number | BLA103375 |
Labeler Name | Baxalta US Inc. |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2009-04-10 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103375 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | EA |
Marketing Start Date | 2009-04-10 |
Marketing Category | Export only |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-03 |
Inactivation Date | 2019-10-21 |
NDC | Brand Name | Generic Name |
---|---|---|
0944-2831 | Recombinate | Antihemophilic Factor Recombinant |
0944-2832 | Recombinate | Antihemophilic Factor Recombinant |
0944-2833 | Recombinate | Antihemophilic Factor Recombinant |
0944-2841 | RECOMBINATE | antihemophilic factor recombinant |
0944-2842 | RECOMBINATE | antihemophilic factor recombinant |
0944-2843 | RECOMBINATE | antihemophilic factor recombinant |
0944-2844 | RECOMBINATE | antihemophilic factor recombinant |
0944-2845 | RECOMBINATE | antihemophilic factor recombinant |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RECOMBINATE 97043921 not registered Live/Pending |
Baxalta Incorporated 2021-09-24 |
RECOMBINATE 74229857 not registered Dead/Abandoned |
Baxter International Inc. 1991-12-12 |
RECOMBINATE 73796939 not registered Dead/Abandoned |
BAXTER INTERNATIONAL INC. 1989-05-01 |